Skip to main content

Table 4 Odds ratios for microRNA expression associated with glycemic impairment

From: Circulating micrornas associated with glycemic impairment and progression in Asian Indians

  Unadjusted Model 1* Model 2**
  OR 95 % CI p-value OR 95 % CI p-value OR 95 % CI p-value
Prevalent Glycemic Impairment
 hsa-miR-191-5p 1.7 1.2, 2.4 0.002 1.6 1.1, 2.3 0.014 1.5 1.1, 2.2 0.026
Progressive Glycemic Impairment After 2.5 Years
 hsa-miR-122-5p 0.5 0.2, 0.8 0.003 0.4 0.3, 0.8 0.003 0.5 0.3, 0.8 0.003
 hsa-miR-15a-5p 0.6 0.4, 0.9 0.040 0.6 0.4, 0.9 0.031 0.6 0.4, 0.9 0.034
 hsa-miR-197-3p 0.6 0.4, 0.9 0.020 0.6 0.4, 0.9 0.016 0.6 0.4, 0.9 0.018
 hsa-miR-320a 0.6 0.4, 0.9 0.038 0.6 0.4, 0.9 0.045 0.6 0.4, 0.9 0.032
 hsa-miR-423-5p 0.6 0.4, 0.9 0.033 0.6 0.4, 0.9 0.039 0.6 0.4, 0.9 0.030
 hsa-miR-486-5p 0.5 0.3, 0.8 0.004 0.4 0.3, 0.8 0.003 0.4 0.3, 0.8 0.003
  1. CI confidence interval, MET metabolic equivalent
  2. microRNAs are scaled by quartile
  3. *Model 1 adjusted for age, sex, and waist circumference
  4. **Model 2 adjusted for variables in Model 1 and HDL-cholesterol and triglycerides